Invention Grant
US07829711B2 Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-C]pyridine-3-yl]-ethane-1,2-dione
有权
1-（4-苯甲酰基 - 哌嗪-1-基）-2- [4-甲氧基-7-（3-甲基 - [1,2,4]三唑-1-基）-1H-吡咯并[2 ，3-C]吡啶-3-基] - 乙烷-1,2-二酮
![Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-C]pyridine-3-yl]-ethane-1,2-dione](/docs/US/2010-11-09/US07829711B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-C]pyridine-3-yl]-ethane-1,2-dione
- Patent Title (中): 1-（4-苯甲酰基 - 哌嗪-1-基）-2- [4-甲氧基-7-（3-甲基 - [1,2,4]三唑-1-基）-1H-吡咯并[2 ，3-C]吡啶-3-基] - 乙烷-1,2-二酮
-
Application No.: US12468105Application Date: 2009-05-19
-
Publication No.: US07829711B2Publication Date: 2010-11-09
- Inventor: John D. Matiskella , Chenkou Wei , Qi Gao , Chong-Hui Gu , Shan-Ming Kuang
- Applicant: John D. Matiskella , Chenkou Wei , Qi Gao , Chong-Hui Gu , Shan-Ming Kuang
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent John F. Levis
- Main IPC: C07D241/04
- IPC: C07D241/04 ; C07D295/00
![Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-C]pyridine-3-yl]-ethane-1,2-dione](/abs-image/US/2010/11/09/US07829711B2/abs.jpg.150x150.jpg)
Abstract:
The instant invention provides crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione; processes for the production of such crystalline materials; pharmaceutical compositions comprising such crystalline materials; and methods of treating HIV or AIDS with such crystalline materials or such pharmaceutical compositions.
Public/Granted literature
Information query
